T1	Participants 147 220	From January 1985 to September 1988, 60 women with advanced breast cancer
T2	Participants 485 676	All patients were post-menopausal, previously untreated with hormone therapy, and with tumor receptor status determined immediately before randomization; all had objectively evaluable lesions
T3	Participants 833 902	Thirty-one and 29 patients were included respectively in arms A and B
#1	AnnotatorNotes T3	Total of 60 participants.
